
Manipal Health Enterprises
OPENIPO Date: 29 Jul - 31 Jul 2026
Listing Date: 5 Aug 2026
Price Range
Rs.560 - Rs.590
Issue Size
9275 Cr
Min Investment
₹14,000
Lot Size
25 Shares
Schedule of Manipal Health Enterprises
Issue open date
29 Jul 2026
Issue close date
31 Jul 2026
UPI mandate deadline
31 Jul 2026 (5 PM)
Allotment finalization
3 Aug 2026
Share credit
4 Aug 2026
Listing date
5 Aug 2026
Mandate end date
15 Aug 2026
Issue size
| Funds Raised in the IPO | Amount |
|---|---|
| Overall | 9275 Cr |
| Fresh Issue | 8000 Cr |
| Offer for Sale | 1275.22 Cr |
Allotment DetailsNew
| Allotment Timeline | Details |
|---|---|
| Allotment Date | 3 Aug 2026 |
| Allotment Link | {Link} |
Grey Market PremiumNew
Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.
| Date | Ipo Price | GMP | Estimated Listing Price |
|---|---|---|---|
| 28 Jul 2026 | ₹590 | ₹10 | ₹600 (1.69%) |
| 27 Jul 2026 | ₹590 | ₹13 | ₹603 (2.2%) |
| 26 Jul 2026 | ₹590 | ₹25 | ₹615 (4.24%) |
| 25 Jul 2026 | ₹590 | ₹25 | ₹615 (4.24%) |
| 24 Jul 2026 | ₹590 | ₹35 | ₹625 (5.93%) |
Performance Manipal Health Enterprises
| Issue Price | Listing Gain | Current Market Price | P/L |
|---|---|---|---|
| Rs.560 - Rs.590 | .... | .... | .... |
About Manipal Health Enterprises
Manipal Health Enterprises operates a pan-India network of multispecialty hospitals that provides healthcare services ranging from outpatient consultations to tertiary and quaternary care. As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds across 14 states and Union Territories. Its clinical services cover specialties, including cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, renal sciences, and other medical disciplines. During the financial year 2026, the company served 7.63 million patients across its network and had 11,064 doctors associated with its hospitals. The company has a presence in both metro and non-metro locations, with hospitals in cities such as Bengaluru, Kolkata, and Pune, alongside facilities in other parts of India. As of March 31, 2026, 41 of its hospitals were accredited by the National Accreditation Board for Hospitals and Healthcare Providers (NABH), while 24 hospital laboratories were accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). Use of proceeds: The IPO consists of both a fresh issue and an offer for sale (OFS). Net proceeds from the OFS will go to the respective selling shareholders, while the net proceeds from the fresh issue will be utilised for the following purposes: Repayment/ prepayment, in full or in part, of certain outstanding borrowings and accrued interest thereon availed by one of its material subsidiaries, Manipal Hospitals Private Limited — Rs 5,552.76 Acquisition of minority stake in its stepdown subsidiary, Sahyadri Hospitals Private Limited — Rs 574 crore General corporate purposes.
| Founded in | 2010 |
| Managing director | Mr Dilip Jose |
| Parent organization |
Financial Overview
Strengths
- A large network of multi-speciality hospitals supported by a wide base of doctors.
- Focus on high-end specialities like cardiac, oncology and neurosciences, driving revenue.
- Strong presence across key regions with ongoing expansion plans.
- Significant share of revenue from insurance and institutional payors.
- Established track record of growth in patient volumes and operations.
Risks
- High dependence on insurance and third-party administrators for revenue.
- Delays in payments from government schemes can impact cash flows.
- Expansion into new regions may face operational and market challenges.
- Failure to attract sufficient patients can lead to underutilised capacity.
- High outstanding receivables may affect working capital and liquidity.
Subscription Figures
| Category | Subscription (No. of times) |
|---|---|
| Qualified Institutional Buyers (QIBs) | N/A |
| Non-Institutional Investors (NIIs) | N/A |
| Retail Individual Investors (RIIs) | N/A |
| Employee | N/A |
| Total | N/A |